{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:04:04Z","timestamp":1783479844422,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Economic Affairs"},{"name":"Dutch Arthritis Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.joca.2018.08.022","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T06:51:42Z","timestamp":1537426302000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials"],"prefix":"10.1016","volume":"27","author":[{"given":"T.S.","family":"de Windt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Niemansburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"van Delden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.B.","family":"Roes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.A.","family":"Dhert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.F.","family":"Saris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Bredenoord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.joca.2018.08.022_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/term.20","article-title":"A\u00a0proposed definition of regenerative medicine","volume":"1","author":"Daar","year":"2007","journal-title":"J\u00a0Regen Med Tissue Eng"},{"key":"10.1016\/j.joca.2018.08.022_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bmb\/ldt034","article-title":"Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies","volume":"108","author":"Ratcliffe","year":"2013","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.joca.2018.08.022_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/rme.13.80","article-title":"The global landscape of stem cell clinical trials","volume":"9","author":"Li","year":"2014","journal-title":"Regen Med"},{"issue":"21\u201322","key":"10.1016\/j.joca.2018.08.022_bib4","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1089\/ten.tea.2012.0169","article-title":"The survey on cellular and engineered tissue therapies in Europe in 2010","volume":"18","author":"Martin","year":"2012","journal-title":"Tissue Eng A"},{"issue":"1","key":"10.1016\/j.joca.2018.08.022_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/rme.12.112","article-title":"Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients","volume":"8","author":"Niemansburg","year":"2013","journal-title":"Regen Med"},{"issue":"19\u201320","key":"10.1016\/j.joca.2018.08.022_bib6","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1089\/ten.tea.2013.0332","article-title":"Stem cell trials for vascular medicine: ethical rationale","volume":"20","author":"Niemansburg","year":"2014","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.joca.2018.08.022_bib7","series-title":"Choice of Control Group in Clinical Trials","author":"European Medicines Agency","year":"2001"},{"key":"10.1016\/j.joca.2018.08.022_bib8","series-title":"Guidance for Industry E10 Choice of Control Group and Related Issues in Clinical Trials","author":"Food and Drug Administration","year":"2001"},{"issue":"4","key":"10.1016\/j.joca.2018.08.022_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.surg.2014.12.001","article-title":"Reconsidering the ethics of sham interventions in an era of emerging technologies","volume":"157","author":"Niemansburg","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.joca.2018.08.022_bib10","series-title":"International Ethical Guidelines for Health-related Research Involving Humans","author":"The Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the WHO","year":"2016"},{"key":"10.1016\/j.joca.2018.08.022_bib11","series-title":"Guidelines for the Clinical Translation of Stem Cells","author":"International Society for Stem Cell Research","year":"2008"},{"issue":"5","key":"10.1016\/j.joca.2018.08.022_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1740774508096705","article-title":"Clinical trials in stem cell transplantation: guidelines for scientific and ethical review","volume":"5","author":"Lo","year":"2008","journal-title":"Clin Trials"},{"key":"10.1016\/j.joca.2018.08.022_bib13","series-title":"Considerations for the Design of Early-phase Clinical Trials of Cellular and Gene Therapy Products","author":"FDA","year":"2013"},{"key":"10.1016\/j.joca.2018.08.022_bib14","series-title":"Reflection Paper on Clinical Aspects Related to Tissue Enginered Products","author":"Committee for Advanced Therapies (CAT)","year":"2012"},{"issue":"2","key":"10.1016\/j.joca.2018.08.022_bib15","first-page":"257","article-title":"Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease","volume":"38","author":"Lo","year":"2010","journal-title":"J\u00a0Law Med Ethics"},{"key":"10.1016\/j.joca.2018.08.022_bib16","series-title":"FDA Guidance for Industry Cellular Therapy for Cardiac Disease","author":"FDA","year":"2010"},{"key":"10.1016\/j.joca.2018.08.022_bib17","series-title":"Reflection Paper on In-vitro Cultured Chrondocyte Containing Products for Cartilage Repair of the Knee","author":"Committee for Advanced Therapies (CAT)","year":"2009"},{"issue":"25 Pt A","key":"10.1016\/j.joca.2018.08.022_bib18","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.jacc.2014.03.045","article-title":"Placebo in autologous cell-based interventions: hard pill to swallow?","volume":"63","author":"Koudstaal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.joca.2018.08.022_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2018.08.022_bib20","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1097\/01.CCM.0000054906.49187.67","article-title":"Ethical framework for the use of sham procedures in clinical trials","volume":"31","author":"Horng","year":"2003","journal-title":"Crit Care Med"},{"issue":"9695","key":"10.1016\/j.joca.2018.08.022_bib21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)61086-2","article-title":"Challenges in evaluating surgical innovation","volume":"374","author":"Ergina","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2018.08.022_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-6215-10-9","article-title":"The challenges faced in the design, conduct and analysis of surgical randomised controlled trials","volume":"10","author":"Cook","year":"2009","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.joca.2018.08.022_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SLA.0b013e3181cf863d","article-title":"Randomized controlled trials of surgical interventions","volume":"251","author":"Farrokhyar","year":"2010","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.joca.2018.08.022_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1191\/0962280202sm300ra","article-title":"Placebos that harm: sham surgery controls in clinical trials","volume":"11","author":"London","year":"2002","journal-title":"Stat Meth Med Res"},{"issue":"9307","key":"10.1016\/j.joca.2018.08.022_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.joca.2018.08.022_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM199410063311401","article-title":"Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation","volume":"331","author":"Brittberg","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.joca.2018.08.022_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrrheum.2013.29","article-title":"Functional articular cartilage repair: here, near, or is the best approach not yet clear?","volume":"9","author":"Mastbergen","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"16","key":"10.1016\/j.joca.2018.08.022_bib28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2106\/JBJS.15.01208","article-title":"A\u00a0randomized multicenter trial comparing autologous chondrocyte implantation with microfracture: long-term follow-up at 14 to 15 years","volume":"98","author":"Knutsen","year":"2016","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"8","key":"10.1016\/j.joca.2018.08.022_bib29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial","volume":"99","author":"Vega","year":"2015","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.joca.2018.08.022_bib30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.arthro.2014.04.007","article-title":"Could the New England Journal of Medicine be biased against arthroscopic knee surgery? Part 2","volume":"30","author":"Lubowitz","year":"2014","journal-title":"Arthroscopy"},{"issue":"3","key":"10.1016\/j.joca.2018.08.022_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15265160802654129","article-title":"What is the best standard for the standard of care in clinical research?","volume":"9","author":"van der Graaf","year":"2009","journal-title":"Am J Bioeth"},{"issue":"1","key":"10.1016\/j.joca.2018.08.022_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1472-6939-15-66","article-title":"The social value of clinical research","volume":"15","author":"Habets","year":"2014","journal-title":"BMC Med Ethics"},{"issue":"3 Suppl","key":"10.1016\/j.joca.2018.08.022_bib33","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1097\/01.CCM.0000054906.49187.67","article-title":"Ethical framework for the use of sham procedures in clinical trials","volume":"31","author":"Horng","year":"2003","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.joca.2018.08.022_bib34","first-page":"332","article-title":"Defining and describing benefit appropriately in clinical trials","volume":"28","author":"King","year":"2000","journal-title":"J\u00a0Law Med Ethics"},{"issue":"11","key":"10.1016\/j.joca.2018.08.022_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/15265160903197606","article-title":"The need to explicate the ethical evaluation tools to avoid ethical inflation","volume":"9","author":"Bernabe","year":"2009","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.joca.2018.08.022_bib36","series-title":"Gene Transfer and the Ethics of First-in-human Research","first-page":"89","article-title":"Looking backward: a model of value for translational trials","author":"Kimmelman","year":"2010"},{"key":"10.1016\/j.joca.2018.08.022_bib37","series-title":"The Oxford Textbook of Clinical Research Ethics","first-page":"606","article-title":"Philosophical justifications of informed consent in research","author":"Brock","year":"2008"},{"issue":"6","key":"10.1016\/j.joca.2018.08.022_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3563896","article-title":"Unnecessary holes in the head","volume":"23","author":"Gillett","year":"2001","journal-title":"IRB"},{"key":"10.1016\/j.joca.2018.08.022_bib39","article-title":"Therapeutic misconception and stem cell research","author":"Cho","year":"2013","journal-title":"Nat Rep Stem Cell"},{"issue":"9 Suppl","key":"10.1016\/j.joca.2018.08.022_bib40","first-page":"V55","article-title":"The therapeutic misconception: problems and solutions","volume":"40","author":"Lidz","year":"2002","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.joca.2018.08.022_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2307\/3564408","article-title":"Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism","volume":"25","author":"Horng","year":"2003","journal-title":"IRB"},{"issue":"13","key":"10.1016\/j.joca.2018.08.022_bib42","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.292.13.1593","article-title":"Interventions to improve research participants' understanding in informed consent for research: a systematic review","volume":"292","author":"Flory","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2018.08.022_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1472-6939-14-28","article-title":"Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials","volume":"14","author":"Nishimura","year":"2013","journal-title":"BMC Med Ethics"},{"issue":"11","key":"10.1016\/j.joca.2018.08.022_bib44","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.socscimed.2003.08.023","article-title":"Patients' perceptions of informed consent in acute myocardial infarction research: a Danish study","volume":"58","author":"Gammelgaard","year":"2004","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.joca.2018.08.022_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/BOR.0b013e32834307eb","article-title":"Osteoarthritis prevention","volume":"23","author":"Neogi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.joca.2018.08.022_bib46","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/ejhg.2010.249","article-title":"Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background document to the ESHG recommendations on genetic testing and common disorders","volume":"19","author":"Becker","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"25","key":"10.1016\/j.joca.2018.08.022_bib47","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/sim.5403","article-title":"Biomarkers and surrogate endpoints in clinical trials","volume":"31","author":"Fleming","year":"2012","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.joca.2018.08.022_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1467-8519.00135","article-title":"Medicalization as a moral problem for preventative medicine","volume":"13","author":"Verweij","year":"1999","journal-title":"Bioethics"},{"issue":"2","key":"10.1016\/j.joca.2018.08.022_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2106\/JBJS.M.00058","article-title":"Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study","volume":"96","author":"Vangsness","year":"2014","journal-title":"J\u00a0Bone Joint Surg Am"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458418314663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458418314663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:48:53Z","timestamp":1761018533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458418314663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1063458418314663"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2018.08.022","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2018.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}